Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs Williams-Sonoma, Inc. (WSM) Price & Performance

BridgeBio Pharma IncTrade
Williams-Sonoma, Inc.Trade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs Williams-Sonoma, Inc. — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while Williams-Sonoma, Inc. trades at $250.52 (market cap $29.51B). The key difference: Williams-Sonoma, Inc. is the larger of the two by market cap, and Williams-Sonoma, Inc. pays a 1.21% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.

BBIOWSM
Market Cap
$16.36B$29.51B
Sector
HealthConsumer Cyclical
52-Week High
$90.17$251.81
52-Week Low
$47.29$168.64
Enterprise Value
$18.14B$30.35B
Dividend Yield
1.21%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About Williams-Sonoma, Inc.

With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.

Read more on WSM